Rain Therapeutics

-$0.05 (-0.34%) Today
$0.00 (0.00%) As of 12:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAIN and other ETFs, options, and stocks.

About RAIN

Rain Therapeutics, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA.

CEO
Avanish Vellanki
Employees
—
Headquarters
Newark, California
Founded
2017

RAIN Key Statistics

Market Cap
390.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
49.07K
High Today
$15.89
Low Today
$14.53
Open Price
$14.79
Volume
69.26K
52 Week High
$23.90
52 Week Low
$11.57

RAIN Earnings

-$1.93
-$1.29
-$0.64
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure